Trials of Germains Seed Treatments new Xbeet enrich 200 show yield benefit

Germains Seed Treatments has launched a new product in its Germains Xbeet^® seed treatment range that will be available for the 2021 season.
Trialled and tested for the UK climate, new Xbeet® enrich 200  treatment includes an extra coating of bio-stimulant, derived from natural plant extracts to help with crop health, accelerate emergence, increase yield and assist the crop to reach the critical twelve-leaf stage and mature plant resistance.
The development aims to help manage yield fluctuations caused by pests and diseases, helping growers achieve consistent returns from their sugar beet crops.
Independent trials for the new Xbeet® enrich 200 have been carried out in collaboration with the BBRO and independent trial specialists and have shown an average yield benefit of 1.4% from Xbeet enrich 200 over Xbeet^® enrich 100 during 3 years of trials. The independent verification of the trial results by Niab have shown the results are significant to the 95% confidence level.
Further commercial scale strip trials in 2018 and 2019 have shown an average of 2.5% increase in yield across three trial sites in the UK. Commercial scale strip trials replicate commercial practice and give an indication of the results growers can expect from farm scale use of a product.
Germains EU Commercial Manager, Richard Nicholls, says: “We are really excited to be bringing our Xbeet® enrich 200 treatment to market. It addresses many of the establishment concerns of UK sugar beet growers. Our trial results have shown a significant yield increase and we look forward to growers seeing the benefits and ultimately the additional income.”
For more information and further data on the Xbeet® enrich 200, and also for your chance to enter a prize draw for a £100 gift voucher, visit germains.com/xbeet-enrich-series/